Scale -

  • Ebitda is 20.7 Rs Cr; Annual Growth is 49 %; in Top Quartile; 5 Year CAGR is 11 %
  • PBT is 0.08 Rs Cr; Annual Growth is 164 %; 5 Year CAGR is 21 %; in Bottom Quartile
  • PAT is 11.1 Rs Cr; Annual Growth is 167 %; in Top Quartile; 5 Year CAGR is 21 %
  • Revenue is 151 Rs Cr; in Top Quartile; 5 Year CAGR is 15 %

Profitability -

  • PBDIT Margin is 13.74 %; Annual Growth is 44 %; in Top Quartile
  • PAT Margin is 7.36 %; Annual Growth is 159 %; in Top Quartile
  • Quarterly Ebitda Margin is 3 %; in Bottom Quartile
  • Quarterly Profit margin is 0 %; in Bottom Quartile

Return -

  • ROCE is 12.36 %; Annual Growth is 39 %
  • ROA is 6.32 %; Annual Growth is 133 %
  • ROE is 11.54 %; Annual Growth is 136 %
  • Asset Turnover is 92 %; Continuous Decline over 3 years

Efficiency -

  • Inventory Turnover Ratio is 5.29; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 23 %
  • Operating cash flow is 15.37 Rs Cr; in Top Quartile; Annual Decline is -31 %
  • Current Ratio is 1.57; Continuous Decline over 3 years
  • Quick Ratio is 1.06; Continuous Decline over 3 years

Solvancy -

  • Contingent Liabilities is 10.34 Rs Cr; Continuous Decline over 3 years; in Top Quartile; 5 Year CAGR is 44 %
  • Total Debt is 37.43 Rs Cr; Annual Growth is 33 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 48 %
  • Debt/Equity is 0.39; Continuous Growth over 3 years; 5 Year CAGR is 32 %
  • Long term Debt is 17.78 Rs Cr; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 23 %

Quality -

  • Change in Inventories/Total Expenses is 0 %; Annual Decline is -102 %
  • Other Expenses/Total Expenses is 7 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cashflow/PAT is 138 %; in Top Quartile; Annual Decline is -74 %
  • Operating cashflow/ebitda is 74 %; Annual Decline is -53 %
  • Exceptional Items/PBT is 0 %; Annual Growth is 100 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Bafna Pharmaceuticals Upper Circuit Today: Price, Data and Peers
Read More
  • Past/current
Bafna Pharmaceuticals Limited Estimates – NSE:BAFNAPH
Read More
  • Past/current
Strides to Take Control of Bafna's India Branded Generics Buisness
Read More
  • Past/current
Bafna Pharmaceuticals BAFNAPH Q2 FY27 Reg 74(5) Certificate
Read More
  • Past/current
Bafna Pharmaceuticals (BAFNAPH.NS) Trades at ?409.85, Up 1.99% as Stock Presses Toward Resistance
Read More
  • Past/current
Bafna Pharmaceuticals (BAFNAPH.NS) Rises 1.99% to ?378.75, Approaches Resistance at ?397.69
Read More
  • Past/current